Open Label, Multicenter, Real World Practice of Durvalumab (Imfinzi PMS)

Clinical trial NCT04068168 · COMPLETED

Trial details

NCT number: NCT04068168
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Cancer, Biliary Tract Cancer

Start date: 2020-01-30
Primary completion: 2024-12-27
Enrollment: 712

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.